Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia

Area of Science:

• Hematology
• Oncology
• Biomedical Engineering

Background:

• Acute nonlymphocytic leukemia (ANLL) is a challenging malignancy.
• Hyperthermia is a potential therapeutic modality.
• Understanding cellular responses to heat is crucial for treatment development.

Purpose of the Study:

• To compare the in vitro heat sensitivity of normal human bone marrow progenitor cells (granulocyte-macrophage colony-forming units, CFU-GM) with clonogenic ANLL cells.
• To evaluate the effect of hyperthermia on primitive normal bone marrow progenitors and stromal cells.

Main Methods:

• Normal bone marrow cells, ANLL patient blasts, and HL-60 cells were incubated at 42-44°C for varying durations.
• Cell viability and clonogenic potential (CFU-GM) were assessed.
• Long-term bone marrow cultures were established to evaluate stromal cell and primitive progenitor responses.

Main Results:

• Leukemic cells (ANLL blasts and HL-60) exhibited significantly greater heat sensitivity than normal bone marrow CFU-GM.
• Exposure to 43°C for 2 hours resulted in 52% survival of normal CFU-GM but only 3% survival of leukemic CFU-GM.
• Normal bone marrow stromal cells and primitive progenitors demonstrated resistance to hyperthermia levels toxic to leukemic cells.

Conclusions:

• Normal bone marrow progenitor and stromal cells are more resistant to hyperthermia than myeloid leukemic cells.
• Differential heat sensitivity suggests ex vivo hyperthermia could be used to purge residual leukemic cells from autologous bone marrow transplants.
• Hyperthermia shows promise as an adjunctive therapy in ANLL treatment protocols.